Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Fig. 3

Univariate and multivariate analyses of 10-year OS in N = 279 cases of ER+, ERBB2 non-amplified ILC. Gray square dot indicates hazard ratio (HR) in univariate analysis and the gray bar indicates the 95% confidence interval (CI). Significant prognostic variables in univariate analyses (where 95% CI does not span HR = 1) are included in multivariate analysis, shown in blue. For each variable, cases with unknown values are excluded from the analysis

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us